Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivir + Kaletra vs Combivir + Reyataz for HIV Post-exposure Prophylaxis
NCT00385645Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- May 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Proportions of patients completing 28-day antiretroviral treatment. Started May 2006; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00385645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385645.